Doxil Shortage Solution: FDA Chooses Middle Ground, Allows Import Of Unapproved Version

FDA is allowing Sun Pharma Global FZE to import its unapproved liposomal version of doxorubicin, Lipodox, to alleviate a shortage, but has not yet given the drug full approval.